KOSDAQ - Delayed Quote KRW

Enzychem Lifesciences Corporation (183490.KQ)

Compare
1,540.00
+40.00
+(2.67%)
At close: January 24 at 3:30:30 PM GMT+9
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-10,257,939.60
-14,319,893.54
-18,588,946.24
-14,020,851.85
Investing Cash Flow
--
53,561,537.56
-109,233,035.74
-9,728,674.17
-45,241,978.24
Financing Cash Flow
--
-35,503,217.26
128,503,765.05
29,263,227.04
58,826,583.23
End Cash Position
--
15,470,224.22
7,683,634.97
2,815,909.79
1,857,599.58
Capital Expenditure
--
-2,302,361.35
-8,012,680.86
-5,882,593.59
-3,096,626.47
Issuance of Capital Stock
--
--
153,713,317.28
290,272.76
224,894.00
Issuance of Debt
--
3,553,820.21
45,670,807.25
7,139,660.00
63,789,673.22
Repayment of Debt
--
-38,411,353.06
-70,357,532.25
-7,478,060.00
-5,165,018.46
Free Cash Flow
--
-12,560,300.95
-22,332,574.40
-24,471,539.83
-17,117,478.32
12/31/2020 - 4/5/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade